FOXO3 and breast cancer: Recently, sumoylation (Lys 527 and Lys633) was associated with the regulation of FOXK2 activity, and its role in mediating the cytotoxic response to paclitaxel through the tumor suppressor FOXO3 in breast cancer cells was recently reported (40) (Figure 3).